{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:39Z","timestamp":1792831059670,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005362","name":"Universit\u00e0 degli Studi di Bari Aldo Moro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"FCT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110599","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:45:38Z","timestamp":1790725538000},"page":"110599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural optimization of donepezil-like hybrids toward an improved multi-target and ADME-related profile"],"prefix":"10.1016","volume":"183","author":[{"given":"Marco","family":"Paparella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalba","family":"Leuci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Simic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00edlvia","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Loiodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Laghezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Wackerlig-Damle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Am\u00e9lia","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Piemontese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110599_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer\u2019s disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2026.110599_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vhri.2023.09.008","article-title":"Economic burden of Alzheimer\u2019s disease: a systematic review","volume":"40","author":"Tay","year":"2024","journal-title":"Value in Health Regional Issues"},{"key":"10.1016\/j.bioorg.2026.110599_bb0015","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bioorg.2026.110599_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1678581","article-title":"Current and future treatments in Alzheimer\u2019s disease","volume":"39","author":"Atri","year":"2019","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0025","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson\u2019s disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.bioorg.2026.110599_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7861\/clinmedicine.16-3-247","article-title":"Drug treatments in Alzheimer\u2019s disease","volume":"16","author":"Briggs","year":"2016","journal-title":"Clin. Med."},{"key":"10.1016\/j.bioorg.2026.110599_bb0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2025.10.011","article-title":"Anti-amyloid monoclonal antibody therapies in Alzheimer\u2019s disease \u2013 a scoping review","volume":"589","author":"Elamin","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.bioorg.2026.110599_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0045","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/B978-0-443-19088-9.00005-6","article-title":"The involvement of the cholinergic system in Alzheimer disease","volume":"211","year":"2025"},{"key":"10.1016\/j.bioorg.2026.110599_bb0050","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.bioorg.2026.110599_bb0055","first-page":"67","article-title":"Combining fatty acid amide hydrolase (FAAH) inhibition with peroxisome proliferator-activated receptor (PPAR) activation: a new potential multi-target therapeutic strategy for the treatment of Alzheimer\u2019s disease","volume":"15","author":"Brunetti","year":"2019","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2026.110599_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114358","article-title":"Structure-based Design of Novel Donepezil-like Hybrids for a multi-target approach to the therapy of Alzheimer\u2019s disease","volume":"237","author":"Brunetti","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107895","article-title":"Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer\u2019s drug candidates","volume":"153","author":"Leuci","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2026.118760","article-title":"Lead optimization of Rivastigmine-like hybrids: impact of nitro group and halogen substitution on multi-target anti-Alzheimer\u2019s activity","volume":"141","author":"Leuci","year":"2026","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030958","article-title":"A new series of aryloxyacetic acids endowed with multi-target activity towards peroxisome proliferator-activated receptors (PPARs), fatty acid amide hydrolase (FAAH), and acetylcholinesterase (AChE)","volume":"27","author":"Leuci","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110599_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118026","article-title":"The first-in-class 1,3,5-Triazine-derived dual 5-HT6R\/FAAH modulators in search for potential drug against neurodegenerative diseases with cognitive impairment","volume":"298","author":"Czarnota-\u0141ydka","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11091631","article-title":"Novel phenothiazine\/donepezil-like hybrids endowed with antioxidant activity for a multi-target approach to the therapy of Alzheimer\u2019s disease","volume":"11","author":"Carocci","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bioorg.2026.110599_bb0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bioorg.2026.110599_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00300","article-title":"Serum Copper, Zinc, and Iron levels in patients with Alzheimer\u2019s disease: a meta-analysis of case-control studies","volume":"9","author":"Li","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bioorg.2026.110599_bb0100","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1039\/D4SC06762B","article-title":"Multi-target-directed therapeutic strategies for Alzheimer\u2019s disease: controlling amyloid-\u03b2 aggregation, metal ion homeostasis, and enzyme inhibition","volume":"16","author":"Yoo","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bioorg.2026.110599_bb0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12640-023-00634-7","article-title":"Challenges and opportunities of metal chelation therapy in trace metals overload-induced Alzheimer\u2019s disease","volume":"41","author":"Chaudhari","year":"2023","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bioorg.2026.110599_bb0110","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.008207","article-title":"The essential elements of Alzheimer\u2019s disease","volume":"296","author":"Lei","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/app10124118","article-title":"Importance of biometals as targets in medicinal chemistry: an overview about the role of zinc (II) chelating agents","volume":"10","author":"Leuci","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.bioorg.2026.110599_bb0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.4103\/NRR.NRR-D-24-00140","article-title":"Role of copper chelating agents: between old applications and new perspectives in neuroscience","volume":"20","author":"Leuci","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.bioorg.2026.110599_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106301","article-title":"The metal ion hypothesis of Alzheimer\u2019s disease and the anti-Neuroinflammatory effect of metal chelators","volume":"131","author":"Chen","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0130","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1039\/C6DT02308H","article-title":"How Zn can impede cu detoxification by chelating agents in Alzheimer\u2019s disease: a proof-of-concept study","volume":"45","author":"Conte-Daban","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110599_bb0135","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40263-024-01093-0","article-title":"Targeting biometals in Alzheimer\u2019s disease with metal chelating agents including Coumarin derivatives","volume":"38","author":"Guck\u00fd","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bioorg.2026.110599_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144924","article-title":"Synthesis and evaluation of novel Indolopyridine derivatives as multi-target directed ligands for Alzheimer\u2019s disease","volume":"1354","author":"Zhao","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110599_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109350","article-title":"Design, synthesis, and multi-target evaluation of Chromone-based derivatives as promising anti-Alzheimer\u2019s disease agents","volume":"168","author":"Lu","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0150","article-title":"Design and synthesis of Tacrine\u2013Coumarin hybrids via click chemistry as multifunctional cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease","volume":"31","author":"Wang","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110599_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.143769","article-title":"Synthesis of novel Benzylpiperazine derivatives as potential anti-Alzheimer agents: biological evaluation, cytotoxicity assessment, molecular docking, and molecular dynamics simulations","volume":"1349","author":"Osmaniye","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110599_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2026.110242","article-title":"Rationally designed phytochemical-derived carbamate hybrids unveiling potent inhibition of cholinesterase and amyloid-\u03b2 peptides","volume":"180","author":"Ghose","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-026-00967-y","article-title":"Design, synthesis, and multitarget evaluation of novel quinolone-based heterocyclic derivatives as acetyl cholinesterase inhibitors for Alzheimer\u2019s disease therapy","volume":"12","author":"Dobariya","year":"2026","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110599_bb0170","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and Nanomolar carbamate-based Butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.07.006","article-title":"Comparative effects of cationic Triarylmethane, Phenoxazine and phenothiazine dyes on horse serum Butyrylcholinesterase","volume":"478","author":"Y\u00fccel","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2026.110599_bb0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cbpa.2010.10.022","article-title":"Redox cycling compounds generate H2O2 in HTS buffers containing strong reducing reagents\u2014real hits or promiscuous artifacts?","volume":"15","author":"Johnston","year":"2011","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0185","article-title":"ABTS\/PP decolorization assay of antioxidant capacity reaction pathways","volume":"21","author":"Ilyasov","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.bioorg.2026.110599_bb0190","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-2009-1068","article-title":"Challenges associated with metal chelation therapy in Alzheimer\u2019s disease","volume":"17","author":"Hegde","year":"2009","journal-title":"JAD"},{"key":"10.1016\/j.bioorg.2026.110599_bb0195","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A perspective on multi-target drugs for Alzheimer\u2019s disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2026.110599_bb0200","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.2174\/0929867328666210218183032","article-title":"Recent multi-target approaches on the development of anti-Alzheimer\u2019s agents integrating metal chelation activity","volume":"28","author":"Chaves","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112734","article-title":"Exploiting the potential of Rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases","volume":"262","author":"Dias","year":"2025","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0210","doi-asserted-by":"crossref","unstructured":"Santos, M.A.; Esteves, M.A.; Vaz, M.C.T.; Sim\u00f6es Goncalves, M.L.S. Siderophore analogues. Chelating properties of a new cyclic diazadihydroxamic acid. Inorg. Chim. Acta 1993, 214, 47\u201355, doi:https:\/\/doi.org\/10.1016\/S0020-1693(00)87525-8.","DOI":"10.1016\/S0020-1693(00)87525-8"},{"key":"10.1016\/j.bioorg.2026.110599_bb0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/DT9930000927","article-title":"A new Iron(III) ion sequestering ligand: synthesis, solution chemistry and electrochemistry","author":"Santos","year":"1993","journal-title":"J. Chem. Soc. Dalton Trans."},{"key":"10.1016\/j.bioorg.2026.110599_bb0220","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0003-2670(01)80616-4","article-title":"A study of some problems in determining the Stoicheiometric proton dissociation constants of complexes by potentiometric titrations using a glass electrode","volume":"38","author":"Irving","year":"1967","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110599_bb0225","doi-asserted-by":"crossref","unstructured":"Smith, R.M.; Martell, A.E. Critical Stability Constants; Springer US: Boston, MA, 1975; (ISBN 978-1-4613-4454-4).","DOI":"10.1007\/978-1-4613-4452-0_1"},{"key":"10.1016\/j.bioorg.2026.110599_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122125","article-title":"Synthesis, characterization and antibacterial activity of novel 1,3-Diethyl-1,3-Bis(4-Nitrophenyl)urea and its metal(II) complexes","volume":"22","author":"Pasdar","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110599_bb0235","doi-asserted-by":"crossref","DOI":"10.1063\/1.4927140","article-title":"Structures of the 2-nitrophenol alkali complexes in solution and the solid state","volume":"143","author":"Reichelt","year":"2015","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bioorg.2026.110599_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1021\/ar50137a004","article-title":"Coordination chemistry and microbial Iron transport","volume":"12","author":"Raymond","year":"1979","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110599_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2026.110599_bb0250","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12921\/cmst.2012.18.02.81-88","article-title":"The log P parameter as a molecular descriptor in the computer-aided drug design \u2013 an overview","volume":"18","author":"Jacek","year":"2012","journal-title":"Comput. Methods Sci. Technol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nucmedbio.2017.03.003","article-title":"LogP, a Yesterday\u2019s Value?","volume":"50","author":"Vraka","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0260","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/bmj.282.6259.212","article-title":"Clinical pharmacology: plasma protein binding of drugs","volume":"282","author":"Lindup","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.bioorg.2026.110599_bb0265","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/jps.23614","article-title":"Plasma protein binding: from discovery to development","volume":"102","author":"Bohnert","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110599_bb0270","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood-brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bioorg.2026.110599_bb0275","doi-asserted-by":"crossref","first-page":"38581","DOI":"10.1021\/acsomega.6c00701","article-title":"From the gut to the brain: modeling intestinal absorption and assessing blood\u2013brain-barrier permeability of small-molecule drugs by IAM chromatography","volume":"11","author":"Simi\u0107","year":"2026","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110599_bb0280","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5599\/admet.553","article-title":"Immobilized artificial membrane chromatography: from medicinal chemistry to environmental sciences","volume":"6","author":"Tsopelas","year":"2018","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.bioorg.2026.110599_bb0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1087057105281656","article-title":"Rapid screening of blood-brain barrier penetration of drugs using the immobilized artificial membrane phosphatidylcholine column chromatography","volume":"11","author":"Yoon","year":"2006","journal-title":"SLAS Discovery"},{"key":"10.1016\/j.bioorg.2026.110599_bb0290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chroma.2015.03.060","article-title":"Insight into the retention mechanism on immobilized artificial membrane chromatography using two stationary phases","volume":"1396","author":"Tsopelas","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.bioorg.2026.110599_bb0295","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/17425250903559873","article-title":"Assessing brain free fraction in early drug discovery","volume":"6","author":"Read","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0300","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.110599_bb0305","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","article-title":"Antioxidant activity applying an improved ABTS radical cation Decolorization assay","volume":"26","author":"Re","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2026.110599_bb0310","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1021\/ed042p375","article-title":"Potentiometric titrations using gran plots: a textbook omission","volume":"42","author":"Rossotti","year":"1965","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.bioorg.2026.110599_bb0315","series-title":"PSEQUAD","author":"Z\u00e9k\u00e1ny","year":"2001"},{"key":"10.1016\/j.bioorg.2026.110599_bb0320","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0039-9140(96)01958-3","article-title":"Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs","volume":"43","author":"Gans","year":"1996","journal-title":"Talanta"},{"key":"10.1016\/j.bioorg.2026.110599_bb0325","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0021-9673(02)00064-X","article-title":"Method for measuring the logarithm of the octanol-water partition coefficient by using short Octadecyl-poly(vinyl alcohol) high-performance liquid chromatography columns","volume":"952","author":"Donovan","year":"2002","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.bioorg.2026.110599_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.06.011","article-title":"A new crystal form of human acetylcholinesterase for exploratory room-temperature crystallography studies","volume":"309","author":"Gerlits","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2026.110599_bb0335","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0340","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s10822-019-00240-w","article-title":"Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R grand challenge 4","volume":"33","author":"El Khoury","year":"2019","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2026.110599_bb0345","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1021\/jm2005145","article-title":"A force field with discrete displaceable waters and Desolvation entropy for hydrated ligand docking","volume":"55","author":"Forli","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110599_bb0350","unstructured":"OpenEye Scientific Software, ROCS, 3.4.0.4, OpenEye Scientific Software, Santa Fe, NM Available online: https:\/\/www.eyesopen.com (accessed on 15 February 2024)."},{"key":"10.1016\/j.bioorg.2026.110599_bb0355","series-title":"Desmond Molecular Dynamics System","author":"Schr\u00f6dinger, LLC","year":"2022"},{"key":"10.1016\/j.bioorg.2026.110599_bb0360","series-title":"The PyMOL Molecular Graphics System, Version 3.1\u20130","author":"Schr\u00f6dinger, LLC","year":"2026"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826011351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:05:57Z","timestamp":1792829157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826011351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":72,"alternative-id":["S0045206826011351"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110599","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural optimization of donepezil-like hybrids toward an improved multi-target and ADME-related profile","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110599"}}